Clinical Trials

Submitted protocols are reviewed by both the Clinical Protocol Review Committee (蜜桃APP SVM Department of Veterinary Clinical Sciences) and 蜜桃APP鈥檚 Institutional Animal and Care Use Committee (IACUC) with the intent to ensure that welfare and confidentiality matters are observed. These reviews are patterned on  鈥淕ood Clinical Practices鈥� for conduct of clinical trials in human medicine. 

Join the Journey: Help Advance Research for Healthier Dogs Worldwide!

The association between chronic passive lead and cadmium exposure and atopic dermatitis in dogs 鈥� a preliminary study.

Heavy metals are present throughout the ecosystem. Heavy metal exposure is associated with a wide variety of health effects in humans and nowadays has become an important health concern. In humans, allergies have been associated with heavy metal exposure. Canine and human allergies share many similarities; therefore, the goal of our study is to see if there is an association between heavy metals exposure and skin allergies in dogs.
We are seeking healthy (non-allergic) dog participants. Sampling is not painful and does not require sedation. At the visit, swab samples will be taken from various areas on the body. As well as 2 teaspoons of blood.

Thank you for helping advance research that will improve the lives of dogs worldwide!

  • Healthy dogs with no signs of skin allergies or ear infection, or active/ malignant tumors
  • One dog per household

If you are interested in participating, please contact Dr. McInnis and Dr. Apostolopoulos at navdlab@lsu.edu 

This trial consists of osteopathic treatments combined with DA2P (distemper, adenovirus type-2, and parvovirus) vaccine.

Osteopathy is a holistic and manual therapy that aims to rebalance all structures in the body, making it more efficient. It is a very popular preventive and palliative therapy for humans and animals in Europe. 

Our research aims to determine if osteopathic manipulation can boost the puppies鈥� specific defense when combined with classic administration of DA2P vaccine.

  • Unvaccinated puppies aged 8 weeks
  • Not receiving other medical treatment
  • Absence of metabolic disease (bloodwork will be run at the first visit)

Puppies will need to be brought in every 3 weeks for vaccine boosters and one last visit 4 weeks after the last vaccine for a total of 5 visits over 91 days.

  • Free bloodwork
  • Free vaccines
  • Free osteopathic treatments

Nancy Welborn, DVM (蜜桃APP 1990), Associate Professor of Community Practice

EMAIL DR. WELBORN

Anais Musso, AO, Clinical Instructor of Animal Osteopathy

EMAIL MS. MUSSO